Working With Your Ketamine Provider

Why Your Relationship With Your Ketamine Provider Matters

Working with your ketamine provider well means treating every troche session as part of a two-way exchange of information, not a one-time prescription refill. A ketamine troche is a lozenge dissolved between the cheek and gum or under the tongue that delivers a measured dose of ketamine, a dissociative anesthetic prescribed off-label for treatment-resistant depression, anxiety, PTSD, and certain chronic pain conditions (see the National Institute of Mental Health's overview of depression for background on treatment-resistant forms). Unlike a daily antidepressant that stays at one dose once titrated, troche therapy involves periodic sessions, dose changes based on how you respond, and ongoing safety monitoring. That makes the quality of your communication with your prescribing provider, whether a psychiatrist, primary care physician, or telehealth clinician, a direct factor in how safe and effective your treatment is. This guide covers how to prepare for appointments, what to report between visits, how to request a dose change, and when a symptom means you should call your provider or go to the emergency room instead of waiting.

Types of Ketamine Providers and Their Roles

Different clinicians offer different strengths, and knowing which type of provider is prescribing your troches helps you know what to expect from the relationship.

Psychiatrists

A psychiatrist is a physician who specializes in diagnosing and treating mental health conditions and can prescribe medication. Psychiatrists prescribing ketamine troches often combine prescription management with psychotherapeutic support, and they are well positioned to monitor for psychiatric complications, adjust other psychiatric medications you take, and put your session experience in clinical context.

Primary Care Physicians and Internists

Some primary care physicians (PCPs) prescribe ketamine troches, typically for pain management or when a patient's psychiatrist is not available. A PCP may be less familiar with ketamine-specific monitoring. If your PCP is your ketamine prescriber, it is reasonable to ask whether they consult current ketamine prescribing guidelines and coordinate with a psychiatric colleague when needed.

Telemedicine Ketamine Providers

Telehealth ketamine platforms operate across multiple states through video visits and are typically staffed by nurse practitioners, physician assistants, or physicians who specialize in ketamine troche prescribing. These providers often see a higher volume of ketamine patients than a typical in-person physician, but your access to them is limited to scheduled video appointments, which makes secure messaging between visits especially important.

Non-Prescribing Therapists

Many patients work with a psychotherapist alongside their prescribing provider. The therapist handles integration work, psychological support, and trauma processing. A therapist cannot adjust your prescription, but their observations are often clinically useful and should be shared with your prescriber, with your consent for records sharing between the two.

Your session log is the single most useful piece of clinical information you can bring to an appointment. If you are not sure what a typical session should look like, our guide to ketamine troche onset, peak, and duration outlines the usual timeline so you can note when your experience differs from it.

What to Communicate During Appointments

Response Assessment

Be specific about whether and how you are responding. Instead of saying a session "sort of helped," describe it in terms your provider can act on: "I notice a mood lift for about three days after each session, then it fades," or "my anxiety has dropped from an 8-10 range down to 5-6 most days." Vague reports make dosing decisions harder than they need to be.

Adverse Effects

Report every adverse effect, even mild ones, including elevated heart rate or blood pressure during sessions, significant nausea, prolonged confusion after a session, anxiety or panic that feels unmanageable, unusual physical symptoms, or any craving or increased urge to use ketamine outside prescribed sessions. Our overview of ketamine troche side effects and discontinuation rates describes which effects are common and which warrant a call to your provider. Do not minimize side effects to protect your prescription. Unreported adverse effects can escalate, and a provider who knows what is happening can usually adjust your plan rather than stopping treatment outright.

Dose Concerns

Tell your provider clearly if a dose feels too low ("my sessions feel very mild and I'm not noticing improvement between them"), too high ("my last session felt too intense and I had significant anxiety"), or just right. Positive feedback is useful information too, since it tells your provider to maintain rather than adjust your regimen.

Life Changes Relevant to Treatment

Let your provider know about major life stressors, sleep or diet disruptions, travel that affects your session schedule, new medical diagnoses, or pregnancy. Ketamine is contraindicated in pregnancy, so this disclosure should happen as soon as you know, not at your next scheduled visit.

Requesting Dose Adjustments

Dose changes are typically initiated by your provider based on your reported response, but you can and should request an adjustment if you believe one is needed. Frame the request around a specific observation rather than a general complaint: "I've had three sessions at 200 mg with only mild effects and no sustained mood improvement between them, and I'd like to discuss increasing the dose," or "the 300 mg sessions are producing more anxiety than I can manage, can we try 250 mg." A provider can act on a specific, data-backed request far more easily than on a vague sense that something isn't working.

Between-Visit Communication

Most ketamine providers set up a specific channel for communication between appointments, such as a patient portal, secure email, or a phone line. Know which one your provider prefers and what response time to expect.

When to Message or Call Between Visits

Use routine messaging for non-urgent questions, such as whether it is safe to delay a session by a week or two for travel. Report any adverse effect that is new, worsening, or concerning as soon as it happens, rather than waiting for your next appointment. Contact your provider or emergency services immediately, without waiting for a scheduled visit, if you experience suicidal ideation, severe mental health deterioration, or another psychiatric emergency.

Building a Productive Long-Term Relationship

The best outcomes in ketamine troche therapy come from an ongoing, honest, collaborative relationship with your provider. That relationship depends on a few habits: being honest about your adherence, use patterns, and response; coming to appointments prepared with data and questions; following through on recommendations between visits, including lifestyle changes and therapy referrals; speaking up if something isn't working or if you feel unheard; and giving weight to your provider's clinical judgment, even when it is more conservative than you would prefer.

If the relationship with your current provider consistently isn't working, whether you feel dismissed, communication is poor, or you have a fundamental disagreement about your treatment plan, it is reasonable to seek a second opinion or change providers. Our ketamine troche safety guide covers the baseline monitoring you should expect from any provider, which can help you evaluate whether a new one meets that standard.

References

According to the World Health Organization, depression affects more than 280 million people worldwide, which is part of why psychiatric oversight matters when ketamine troches are prescribed off-label for treatment-resistant depression.

• StatPearls: Ketamine, a clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
• PubChem: Ketamine Compound Summary, the NCBI chemical database entry with ketamine molecular data and pharmacokinetics
• MedlinePlus: Drug Information, National Library of Medicine consumer drug information resources
• NIMH: Depression, National Institute of Mental Health overview of depressive disorders and treatment-resistant forms
• WHO: Depression Fact Sheet, World Health Organization global data on depression prevalence and treatment approaches